Meeting the clinical trials challenge – how Synexus can help the pharmaceutical industry make real changes

Amongst the many challenges facing the pharmaceutical industry today, improving the cost-effectiveness and speed of early phase clinical trials sit at the top of the list. The industry must continue to achieve high rates of growth whilst fending off the impact of the loss of lucrative patents, coping with the competition from existing generics and building on what is seen as a thin pipeline. The traditional phases of drug development need to be streamlined whilst continuing to meet stringent regulations across the globe.

Commenting on the importance of innovation and the ability to react quickly and positively to changes in the industry, Chris said: "Whether we at Synexus are looking at ways to recruit patients more quickly at Phase II, using better patient pre-qualification techniques for example, or whether we are considering ways to minimise data queries at the end of a study, we must ensure that cutting total delivered cost whilst improving the quality of the final outcome are paramount so that the client can reach the most reliable go/no go decision in as short a time as possible. My presentation for this conference, focuses on the ways Synexus is helping our pharma clients work smarter and faster."

Hannigan continues: "This conference is the ideal forum to share our ideas with some of the leading industry figures and to look for ways to work together to ensure innovation remains at the heart of what the clinical trials